Literature DB >> 23507781

Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges.

G T Finosh1, Muthu Jayabalan.   

Abstract

Regeneration of myocardium through regenerative therapy and tissue engineering is appearing as a prospective treatment modality for patients with end-stage heart failure. Focusing on this area, this review highlights the new developments and challenges in the regeneration of myocardial tissue. The role of various cell sources, calcium ion and cytokine on the functional performance of regenerative therapy is discussed. The evolution of tissue engineering and the role of tissue matrix/scaffold, cell adhesion and vascularisation on tissue engineering of cardiac tissue implant are also discussed.

Entities:  

Keywords:  end-stage cardiac failure; new developments and challenges; regenerative therapy; tissue engineering

Mesh：

Substances：

Year:  2012        PMID： 23507781      PMCID： PMC3849053          DOI： 10.4161/biom.19429

Source DB:  PubMed          Journal:  Biomatter        ISSN： 2159-2527


  152 in total

1.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes.

Authors:  W H Zimmermann; C Fink; D Kralisch; U Remmers; J Weil; T Eschenhagen
Journal:  Biotechnol Bioeng       Date:  2000-04-05       Impact factor: 4.530

Review 2.  HIF-1 as a target for drug development.

Authors:  Amato Giaccia; Bronwyn G Siim; Randall S Johnson
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

3.  Controlling the cellular organization of tissue-engineered cardiac constructs.

Authors:  Maya Gonen-Wadmany; Lior Gepstein; Dror Seliktar
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

4.  Adult stem cells, scaffolds for in vivo and in vitro myocardial tissue engineering.

Authors:  Valentina Di Felice; Angela De Luca; Claudia Serradifalco; Patrizia Di Marco; Lucia Verin; Antonella Motta; Annalisa Guercio; Giovanni Zummo
Journal:  Ital J Anat Embryol       Date:  2010

Review 5.  Growth factors in development, transformation, and tumorigenesis.

Authors:  M Cross; T M Dexter
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

6.  Myocardial homing after intrapericardial infusion of bone marrow mononuclear cells.

Authors:  Erika Branco; Emerson Ticona Fioretto; Rosa Cabral; Carlos Alberto Sarmento Palmera; Guilherme Buzon Gregores; Angelo João Stopiglia; Paulo César Maiorka; Pedro Alves Lemos; Carlos Campos; Celso Takimura; José Antônio Franchini Ramires; Maria Angelica Miglino
Journal:  Arq Bras Cardiol       Date:  2009-09       Impact factor: 2.000

7.  Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel.

Authors:  H H Vandenburgh; P Karlisch; L Farr
Journal:  In Vitro Cell Dev Biol       Date:  1988-03

8.  In situ immobilization of proteins and RGD peptide on polyurethane surfaces via poly(ethylene oxide) coupling polymers for human endothelial cell growth.

Authors:  Dong-an Wang; Jian Ji; Yong-hong Sun; Jia-cong Shen; Lin-xian Feng; Jennifer H Elisseeff
Journal:  Biomacromolecules       Date:  2002 Nov-Dec       Impact factor: 6.988

9.  Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts.

Authors:  Keiji Matsubayashi; Paul W M Fedak; Donald A G Mickle; Richard D Weisel; Tsukasa Ozawa; Ren-Ke Li
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

10.  Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.

Authors:  Ken-ichi Hiasa; Minako Ishibashi; Kisho Ohtani; Shujiro Inoue; Qingwei Zhao; Shiro Kitamoto; Masataka Sata; Toshihiro Ichiki; Akira Takeshita; Kensuke Egashira
Journal:  Circulation       Date:  2004-05-17       Impact factor: 29.690
View more
  7 in total

1.  Fluoroscopy Guided Minimally Invasive Swine Model of Myocardial Infarction by Left Coronary Artery Occlusion for Regenerative Cardiology.

Authors:  Finosh G Thankam; Mohamed Radwan; Angelo Keklikian; Manreet Atwal; Taj Rai; Devendra K Agrawal
Journal:  Cardiol Cardiovasc Med       Date:  2022-08-24

2.  PEG-penetrated chitosan-alginate co-polysaccharide-based partially and fully cross-linked hydrogels as ECM mimic for tissue engineering applications.

Authors:  Anitha Radhakrishnan; Geena Mariya Jose; Muraleedhara Kurup
Journal:  Prog Biomater       Date:  2015-09-15

Review 3.  3D bioprinting of cardiac tissue: current challenges and perspectives.

Authors:  Brian Kato; Gary Wisser; Devendra K Agrawal; Tim Wood; Finosh G Thankam
Journal:  J Mater Sci Mater Med       Date:  2021-05-06       Impact factor: 3.896

Review 4.  Alginate for cardiac regeneration: From seaweed to clinical trials.

Authors:  Albert Liberski; Najma Latif; Christophe Raynaud; Christian Bollensdorff; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2016-03-31

Review 5.  Biomaterials-Driven Sterile Inflammation.

Authors:  Henry Chen; Devendra K Agrawal; Finosh G Thankam
Journal:  Tissue Eng Part B Rev       Date:  2021-02-23       Impact factor: 6.389

Review 6.  Myocardial tissue engineering using electrospun nanofiber composites.

Authors:  Pyung-Hwan Kim; Je-Yoel Cho
Journal:  BMB Rep       Date:  2016-01       Impact factor: 4.778

Review 7.  Natural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution.

Authors:  Qasim A Majid; Annabelle T R Fricker; David A Gregory; Natalia Davidenko; Olivia Hernandez Cruz; Richard J Jabbour; Thomas J Owen; Pooja Basnett; Barbara Lukasiewicz; Molly Stevens; Serena Best; Ruth Cameron; Sanjay Sinha; Sian E Harding; Ipsita Roy
Journal:  Front Cardiovasc Med       Date:  2020-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.